#mdgl

Setting 52 Week High, Madrigal Pharmaceuticals Inc (Nasdaq:MDGL) Ends The Day At $274.42

Madrigal Pharmaceuticals Inc (Nasdaq:MDGL)

June 1st, 2018

With markets going up Madrigal Pharmaceuticals Inc went up $8.81 Saturday which equals a 3.32% increase, closing at $274.42. In addition it hit a new 52 week high of $279.80. Madrigal Pharmaceuticals Inc swung 13.66% between low and high. The stock continues to trade well at 1,996% of its 52 week low of $13.09. In addition to finishing…

Hitting 52 Week High, Madrigal Pharmaceuticals Inc (Nasdaq:MDGL) Ends The Day At $265.61

Madrigal Pharmaceuticals Inc (Nasdaq:MDGL)

May 31st, 2018

Amidst falling markets Madrigal Pharmaceuticals Inc went up $157.18 Thursday, a 144.96% increase, closing at $265.61. In addition it hit a new 52 week high of $273.19. The stock continues to trade well at 1,929% of its 52 week low of $13.09. In addition to finishing higher, trading volumes were solid at 2,695% of normal which can indicate…

Analyst Activity – JMP Securities Initiates Coverage On Madrigal Pharmaceuticals (NASDAQ:MDGL) With a Outperform

Analyst Ratings For Madrigal Pharmaceuticals (NASDAQ:MDGL) Today, JMP Securities initiated coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Outperform. There are 1 buy rating on the stock. The current consensus rating on Madrigal Pharmaceuticals (NASDAQ:MDGL) is Buy (Score: 3.00) with a consensus target price of per share, a potential . Some recent analyst ratings include 1/3/2017-JMP…